Akston Biosciences: "Akston Biosciences Signs Licensing Agreement with Dechra Pharma for AKS-425c, a Once-a-Week Insulin Therapy for Cats Follows earlier agreement between Akston and Dechra for AKS-321d, a once-a-week insulin therapy for dogs"

12.30.2023

2023 Press Releases

08.08.2023

Hebrew SeniorLife: “Seniors at NewBridge on the Charles and Orchard Cove Award Educational Scholarships to Staff Employees at Hebrew Seniorlife have benefited from $985,000 in scholarships raised by residents since inception” (Aug. 8, 2023)

01.23.2023

Birnbach Communications Issues Key Media, Business and Tech Predictions for 2023

12.31.2022

2022 Press Releases

Akston Biosciences: “Akston Biosciences Signs Licensing Agreement with Dechra Pharma for AKS-425c, a Once-a-Week Insulin Therapy for Cats Follows earlier agreement between Akston and Dechra for AKS-321d, a once-a-week insulin therapy for dogs”

Related Posts